A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of lateral orbital rhytides

被引:29
作者
Carruthers, Alastair [1 ]
Bogle, Melissa
Carruthers, Jean D. A.
Dover, Jeffrey S.
Arndt, Kenneth A.
Hsu, Te-Shao
Poirier, Jude
机构
[1] Univ British Columbia, Dept Dermatol, Vancouver, BC V5Z 1M9, Canada
[2] Univ British Columbia, Dept Ophthalmol, Vancouver, BC V5Z 1M9, Canada
[3] Laser & Cosmet Surg Ctr, Houston, TX USA
[4] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA
[5] Dartmouth Coll Sch Med, Dept Med Dermatol, Hanover, NH USA
[6] Harvard Univ, Sch Med, Dept Dermatol, Cambridge, MA 02138 USA
[7] Carruthers Clin Res, Vancouver, BC, Canada
关键词
D O I
10.1111/j.1524-4725.2007.33115.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background There has been considerable discussion about the effect of the degree of dilution of botulinum toxin (BTX) but very few scientific studies. Objective The objective was to observe as to whether a fivefold difference in concentration of BTX solution would produce a difference in clinical effect or duration of effect. Methods and Materials Twenty individuals were enrolled at two sites and a within-subject paired-comparison study was performed on the lateral orbital area with a single injection of 5 U of BTX (BOTOX Cosmetic, Allergan Inc., Irvine, CA). The results were assessed both clinically and using a computer-assisted estimation of the degree of wrinkling. ResultsNo statistically significant differences were observed between the two sides. Conclusions This is a small study and it may be that dilution does affect BTX result. We were, however, unable to detect any difference in this study, which suggests that the degree of dilution, at least within a fivefold margin, has only a small effect on the results of BTX injection in the lateral orbital area.
引用
收藏
页码:567 / 571
页数:5
相关论文
共 15 条
[1]  
Blitzer A, 1997, ARCH OTOLARYNGOL, V123, P389
[2]  
BLITZER A, 1993, ARCH OTOLARYNGOL, V119, P1018
[3]  
Carruthers A, 1994, COSMET DERMATOL, V7, P11
[4]   Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: Does it matter? [J].
Carruthers, Alastair ;
Carruthers, Jean ;
Cohen, Joel .
DERMATOLOGIC SURGERY, 2007, 33 :S97-S104
[5]   Consensus recommendations on the use of botulinum toxin type a in facial aesthetics [J].
Carruthers, J ;
Fagien, S ;
Matarasso, SL .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2004, 114 (06) :1S-22S
[6]  
CARRUTHERS JA, 2004, J CLIN RES, V7, P1
[7]   TREATMENT OF GLABELLAR FROWN LINES WITH C-BOTULINUM-A EXOTOXIN [J].
CARRUTHERS, JDA ;
CARRUTHERS, JA .
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1992, 18 (01) :17-21
[8]   Botulinum toxin type A injections:: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases [J].
Coté, TR ;
Mohan, AK ;
Polder, JA ;
Walton, MK ;
Braun, MM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (03) :407-415
[9]   AESTHETIC INDICATIONS FOR BOTULINUM TOXIN INJECTION [J].
GUYURON, B ;
HUDDLESTON, SW .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1994, 93 (05) :913-918
[10]   Botulinum A toxin for glabellar wrinkles - Dose and response [J].
Hankins, CL ;
Strimling, R ;
Rogers, GS .
DERMATOLOGIC SURGERY, 1998, 24 (11) :1181-1183